In Vitro Signaling Properties of Cannabinoid and Orexin Receptors: How Orexin Receptors Influence Cannabinoid Receptor‐Mediated Signaling
Pharmacology Research & Perspectives · 2025
DOI: 10.1002/prp2.70078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Kawthar A Mohamed und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Hauptthemen laut MEDLINE: Orexin Receptors, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, Receptors, Cannabinoid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
The co‐expression of different types of G protein‐coupled receptors (GPCRs) in the same cells can have implications for receptor signaling and receptor cross‐talk, potentially altering the apparent potency or efficacy of ligands targeting each receptor. The endocannabinoid and orexinergic systems, consisting of class A GPCRs and their endogenous ligands, are highly complex and regulate processes such as appetite, sleep, nociception, and energy homeostasis. The shared anatomical distribution of cannabinoid and orexin receptors in various regions of the central nervous system (CNS), coupled with data from previous studies exploring physical and functional interactions between these receptors, suggests that the endocannabinoid and orexinergic systems engage in crosstalk. In this study, we explored how orexin receptors (OX 1 , OX 2 ) altered the in vitro signaling of cannabinoid receptors (CB 1 , CB 2 ) in Chinese hamster ovary (CHO)‐K1 cells by quantifying cyclic adenosine monophosphate (cAMP) inhibition and βarrestin2 recruitment. Our results suggest that orexin receptors alter agonist‐dependent signaling at the cannabinoid receptors by enhancing cannabinoid receptor‐mediated cAMP inhibition while increasing or decreasing cannabinoid receptor‐mediated βarrestin2 recruitment. These initial results are important for understanding the effects associated with cannabinoid ligands and may provide novel insights for therapeutics targeting physiological processes modulated by both systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
- Department of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
ORCID-Profile: Robert B Laprairie
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Mohamed, K. A., & Laprairie, R. B. (2025). In Vitro Signaling Properties of Cannabinoid and Orexin Receptors: How Orexin Receptors Influence Cannabinoid Receptor‐Mediated Signaling. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70078
Vancouver
Mohamed KA, Laprairie RB. In Vitro Signaling Properties of Cannabinoid and Orexin Receptors: How Orexin Receptors Influence Cannabinoid Receptor‐Mediated Signaling. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70078
BibTeX
@article{Mohamed2025,
author = {Mohamed, Kawthar A and Laprairie, Robert B},
title = {In Vitro Signaling Properties of Cannabinoid and Orexin Receptors: How Orexin Receptors Influence Cannabinoid Receptor‐Mediated Signaling},
journal = {Pharmacology Research & Perspectives},
year = {2025},
doi = {10.1002/prp2.70078}
}
EUVIMED